0 Ratings

ID

24169

Description

Study ID: 100577 Clinical Study ID: 100577 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Tracking Document, Long Term Follow-up

Link

https://clinicaltrials.gov/ct2/show/NCT00289757

Keywords

  1. 7/27/17 7/27/17 -
Uploaded on

July 27, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Serious Long Term Follow-up 100577

    Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100577

    Long Term Follow-up
    Description

    Long Term Follow-up

    Alias
    UMLS CUI-1
    C1517942 (Long-term Follow-up)
    UMLS CUI-2
    C0170300 (Hepatitis A Vaccines)
    SNOMED
    871751006
    Subject number of previous study
    Description

    Subject number of previous study

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    UMLS CUI [1,2]
    C2242969 (clinical trial participant (history))
    Subject initials
    Description

    Subject initials

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2986440 (Person Initials)
    UMLS CUI [1,2]
    C0681850 (Study Subject)
    Date of birth
    Description

    Date of birth

    Data type

    date

    Alias
    UMLS CUI [1]
    C0421451 (Patient date of birth)
    SNOMED
    184099003
    LOINC
    LP57552-9
    Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
    Description

    long-term follow-up study participation

    Data type

    integer

    Alias
    UMLS CUI [1,1]
    C2348568 (Study Subject Participation Status)
    UMLS CUI [1,2]
    C1517942 (Long-term Follow-up)
    UMLS CUI [1,3]
    C0170300 (Hepatitis A Vaccines)
    SNOMED
    871751006
    Subject eligible but not willing to participate due to:
    Description

    long-term follow-up study participation

    Data type

    integer

    Alias
    UMLS CUI [1,1]
    C2348568 (Study Subject Participation Status)
    UMLS CUI [1,2]
    C1517942 (Long-term Follow-up)
    UMLS CUI [1,3]
    C0170300 (Hepatitis A Vaccines)
    SNOMED
    871751006
    If adverse events, or serious adverse event, please specify
    Description

    Subject eligible but not willing to participate due to

    Data type

    text

    Alias
    UMLS CUI [1]
    C0877248 (Adverse event)
    LOINC
    MTHU014542
    UMLS CUI [2,1]
    C2348568 (Study Subject Participation Status)
    UMLS CUI [2,2]
    C1517942 (Long-term Follow-up)
    UMLS CUI [2,3]
    C0170300 (Hepatitis A Vaccines)
    SNOMED
    871751006
    If Other, please specify
    Description

    Subject eligible but not willing to participate due to

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2348568 (Study Subject Participation Status)
    UMLS CUI [1,2]
    C1517942 (Long-term Follow-up)
    UMLS CUI [1,3]
    C0170300 (Hepatitis A Vaccines)
    SNOMED
    871751006
    Investigator signature
    Description

    Investigator signature

    Data type

    text

    Alias
    UMLS CUI [1]
    C2346576 (Investigator Signature)
    Investigator signature date
    Description

    Investigator signature date

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C2346576 (Investigator Signature)
    UMLS CUI [1,2]
    C0011008 (Date in time)
    SNOMED
    410671006

    Similar models

    Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100577

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Long Term Follow-up
    C1517942 (UMLS CUI-1)
    C0170300 (UMLS CUI-2)
    Subject number of previous study
    Item
    Subject number of previous study
    text
    C2348585 (UMLS CUI [1,1])
    C2242969 (UMLS CUI [1,2])
    Subject initials
    Item
    Subject initials
    text
    C2986440 (UMLS CUI [1,1])
    C0681850 (UMLS CUI [1,2])
    Date of birth
    Item
    Date of birth
    date
    C0421451 (UMLS CUI [1])
    Item
    Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
    integer
    C2348568 (UMLS CUI [1,1])
    C1517942 (UMLS CUI [1,2])
    C0170300 (UMLS CUI [1,3])
    Code List
    Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
    CL Item
    Subject not eligible (1)
    CL Item
    Subject lost to follow-up or not reached  (2)
    CL Item
    Subject eligible but not willing to participate due to: (3)
    CL Item
    Subject eligible and agreed to participate in the long-term follow-up study (4)
    Item
    Subject eligible but not willing to participate due to:
    integer
    C2348568 (UMLS CUI [1,1])
    C1517942 (UMLS CUI [1,2])
    C0170300 (UMLS CUI [1,3])
    Code List
    Subject eligible but not willing to participate due to:
    CL Item
    adverse events, or serious adverse event (1)
    CL Item
    Other (2)
    long-term follow-up study participation
    Item
    If adverse events, or serious adverse event, please specify
    text
    C0877248 (UMLS CUI [1])
    C2348568 (UMLS CUI [2,1])
    C1517942 (UMLS CUI [2,2])
    C0170300 (UMLS CUI [2,3])
    long-term follow-up study participation
    Item
    If Other, please specify
    text
    C2348568 (UMLS CUI [1,1])
    C1517942 (UMLS CUI [1,2])
    C0170300 (UMLS CUI [1,3])
    Investigator signature
    Item
    Investigator signature
    text
    C2346576 (UMLS CUI [1])
    Investigator signature date
    Item
    Investigator signature date
    date
    C2346576 (UMLS CUI [1,1])
    C0011008 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial